Elisa Kieback

908 total citations
15 papers, 697 citations indexed

About

Elisa Kieback is a scholar working on Oncology, Immunology and Genetics. According to data from OpenAlex, Elisa Kieback has authored 15 papers receiving a total of 697 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 12 papers in Immunology and 5 papers in Genetics. Recurrent topics in Elisa Kieback's work include CAR-T cell therapy research (12 papers), Immunotherapy and Immune Responses (9 papers) and Immune Cell Function and Interaction (8 papers). Elisa Kieback is often cited by papers focused on CAR-T cell therapy research (12 papers), Immunotherapy and Immune Responses (9 papers) and Immune Cell Function and Interaction (8 papers). Elisa Kieback collaborates with scholars based in Germany, United States and United Kingdom. Elisa Kieback's co-authors include Wolfgang Uckert, Daniel Sommermeyer, Annelies Jorritsma, Laura Bies, Ji‐Ying Song, Ton N. Schumacher, Andrew Kaiser, Gavin Bendle, Moniek A. de Witte and John B.A.G. Haanen and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Medicine and Blood.

In The Last Decade

Elisa Kieback

13 papers receiving 690 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Elisa Kieback Germany	10	544	444	273	185	60	15	697
Simon Grassmann Germany	15	455 0.8×	492 1.1×	112 0.4×	208 1.1×	126 2.1×	22	792
Lisa Marie Serrano United States	8	459 0.8×	268 0.6×	169 0.6×	116 0.6×	89 1.5×	9	543
Bianca Weißbrich Germany	8	322 0.6×	443 1.0×	87 0.3×	124 0.7×	40 0.7×	10	594
Anna Thomas United States	7	304 0.6×	360 0.8×	100 0.4×	105 0.6×	38 0.6×	10	527
Cary Hsu United States	9	309 0.6×	250 0.6×	135 0.5×	185 1.0×	35 0.6×	11	463
Sandhya Sharma United States	10	641 1.2×	242 0.5×	261 1.0×	251 1.4×	118 2.0×	21	735
Tamara Laskowski United States	7	395 0.7×	403 0.9×	76 0.3×	201 1.1×	90 1.5×	8	645
Sarah Oelsner Germany	8	651 1.2×	601 1.4×	99 0.4×	125 0.7×	76 1.3×	8	758
Ryo Hanajiri Japan	10	452 0.8×	200 0.5×	170 0.6×	162 0.9×	163 2.7×	29	576
Degui Geng United States	9	308 0.6×	321 0.7×	84 0.3×	139 0.8×	130 2.2×	14	565

Countries citing papers authored by Elisa Kieback

Since Specialization

Citations

This map shows the geographic impact of Elisa Kieback's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elisa Kieback with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elisa Kieback more than expected).

Fields of papers citing papers by Elisa Kieback

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elisa Kieback. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elisa Kieback. The network helps show where Elisa Kieback may publish in the future.

Co-authorship network of co-authors of Elisa Kieback

This figure shows the co-authorship network connecting the top 25 collaborators of Elisa Kieback. A scholar is included among the top collaborators of Elisa Kieback based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elisa Kieback. Elisa Kieback is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

1.

Leisegang, Matthias, Cäcilia Freund, Gerald Willimsky, et al.. (2025). A CD22-specific T-cell receptor enables effective adoptive T-cell therapy for B-cell malignancies. Blood. 147(10). 1058–1069.

2.

Kieback, Elisa, Stephen F. Marino, Felix Oden, et al.. (2018). CAR T Cells with Enhanced Sensitivity to B Cell Maturation Antigen for the Targeting of B Cell Non-Hodgkin’s Lymphoma and Multiple Myeloma. Molecular Therapy. 26(8). 1906–1920. 40 indexed citations

3.

Wisskirchen, Karin, Theresa Asen, Luise Weigand, et al.. (2017). Isolation and functional characterization of hepatitis B virus-specific T-cell receptors as new tools for experimental and clinical use. PLoS ONE. 12(8). e0182936–e0182936. 28 indexed citations

4.

Kieback, Elisa, et al.. (2017). Unbiased Identification of T-Cell Receptors Targeting Immunodominant Peptide–MHC Complexes for T-Cell Receptor Immunotherapy. Human Gene Therapy. 28(12). 1158–1168. 14 indexed citations

5.

Kieback, Elisa, Ellen Hilgenberg, Ulrik Stervbo, et al.. (2016). Thymus-Derived Regulatory T Cells Are Positively Selected on Natural Self-Antigen through Cognate Interactions of High Functional Avidity. Immunity. 44(5). 1114–1126. 76 indexed citations

6.

Wilde, Susanne, Katrin Voigt, Elisa Kieback, et al.. (2015). Codon Optimization of the Human Papillomavirus E7 Oncogene Induces a CD8+ T Cell Response to a Cryptic Epitope Not Harbored by Wild-Type E7. PLoS ONE. 10(3). e0121633–e0121633. 9 indexed citations

7.

Kieback, Elisa, Ellen Hilgenberg, & Simon Fillatreau. (2014). A Method for the Generation of TCR Retrogenic Mice. Methods in molecular biology. 1193. 117–126. 2 indexed citations

8.

Lehmann, F., Elisa Kieback, Wolfgang Uckert, et al.. (2014). Targeting high‐grade B cell lymphoma with CD19‐specific T cells. International Journal of Cancer. 135(5). 1153–1164. 1 indexed citations

9.

Kieback, Elisa, et al.. (2012). Safety Modality for X-linked Severe Combined Immunodeficiency Gene Therapy. 3(3).

10.

Kieback, Elisa & Wolfgang Uckert. (2010). Enhanced T cell receptor gene therapy for cancer. Expert Opinion on Biological Therapy. 10(5). 749–762. 9 indexed citations

11.

Bendle, Gavin, Carsten Linnemann, Anna I. Hooijkaas, et al.. (2010). Lethal graft-versus-host disease in mouse models of T cell receptor gene therapy. Nature Medicine. 16(5). 565–570. 324 indexed citations

12.

Leisegang, Matthias, Boris Engels, Elisa Kieback, et al.. (2008). Enhanced functionality of T cell receptor-redirected T cells is defined by the transgene cassette. Journal of Molecular Medicine. 86(7). 855–855. 5 indexed citations

13.

Leisegang, Matthias, Boris Engels, Elisa Kieback, et al.. (2008). Enhanced functionality of T cell receptor-redirected T cells is defined by the transgene cassette. Journal of Molecular Medicine. 86(5). 573–583. 99 indexed citations

14.

Kieback, Elisa, Jehad Charo, Daniel Sommermeyer, Thomas Blankenstein, & Wolfgang Uckert. (2008). A safeguard eliminates T cell receptor gene-modified autoreactive T cells after adoptive transfer. Proceedings of the National Academy of Sciences. 105(2). 623–628. 76 indexed citations

15.

Kieback, Elisa & Martin Müller. (2005). Factors influencing subcellular localization of the human papillomavirus L2 minor structural protein. Virology. 345(1). 199–208. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact